Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2014 (2014), Article ID 908539, 18 pages
http://dx.doi.org/10.1155/2014/908539
Review Article

Oxidative Stress and Metabolic Pathologies: From an Adipocentric Point of View

1INSERM UMR 1063, “Stress Oxydant et Pathologies Métaboliques”, Institut de Biologie en Santé, 4 rue Larrey, 49933 Angers, France
2Department of Biochemistry, Université d’Angers, CHU Angers, 4 rue Larrey, 49933 Angers Cedex 9, France

Received 12 February 2014; Revised 20 May 2014; Accepted 26 June 2014; Published 20 July 2014

Academic Editor: Jeannette Vasquez-Vivar

Copyright © 2014 Soazig Le Lay et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Zhang, R. Proenca, M. Maffei, M. Barone, L. Leopold, and J. M. Friedman, “Positional cloning of the mouse obese gene and its human homologue,” Nature, vol. 372, no. 6505, pp. 425–432, 1994. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Cao, “Adipocytokines in obesity and metabolic disease,” Journal of Endocrinology, vol. 220, no. 2, pp. T47–T59, 2014. View at Publisher · View at Google Scholar
  3. K. L. Spalding, E. Arner, P. O. Westermark et al., “Dynamics of fat cell turnover in humans,” Nature, vol. 453, no. 7196, pp. 783–787, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. S. P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R. L. Leibel, and A. W. Ferrante Jr., “Obesity is associated with macrophage accumulation in adipose tissue,” Journal of Clinical Investigation, vol. 112, no. 12, pp. 1796–1808, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. U. Kintscher, M. Hartge, K. Hess et al., “T-lymphocyte infiltration in visceral adipose tissue: A primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 7, pp. 1304–1310, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Qatanani and M. A. Lazar, “Mechanisms of obesity-associated insulin resistance: many choices on the menu,” Genes & Development, vol. 21, no. 12, pp. 1443–1455, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. M. F. Gregor and G. S. Hotamisligil, “Inflammatory mechanisms in obesity,” Annual Review of Immunology, vol. 29, pp. 415–445, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. C. K. Roberts and K. K. Sindhu, “Oxidative stress and metabolic syndrome,” Life Sciences, vol. 84, no. 21-22, pp. 705–712, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. H. K. Vincent and A. G. Taylor, “Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans,” International Journal of Obesity, vol. 30, no. 3, pp. 400–418, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Sankhla, T. K. Sharma, K. Mathur et al., “Relationship of oxidative stress with obesity and its role in obesity induced metabolic syndrome,” Clinical Laboratory, vol. 58, no. 5-6, pp. 385–392, 2012. View at Google Scholar · View at Scopus
  11. C. Chrysohoou, D. B. Panagiotakos, C. Pitsavos et al., “The implication of obesity on total antioxidant capacity in apparently healthy men and women: the ATTICA study,” Nutrition, Metabolism & Cardiovascular Diseases, vol. 17, no. 8, pp. 590–597, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Houstis, E. D. Rosen, and E. S. Lander, “Reactive oxygen species have a causal role in multiple forms of insulin resistance,” Nature, vol. 440, no. 7086, pp. 944–948, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Konrad, P. Vicini, K. Kusterer et al., “α-lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes,” Diabetes Care, vol. 22, no. 2, pp. 280–287, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Furukawa, T. Fujita, M. Shimabukuro et al., “Increased oxidative stress in obesity and its impact on metabolic syndrome,” Journal of Clinical Investigation, vol. 114, no. 12, pp. 1752–1761, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. M. P. Murphy, “How mitochondria produce reactive oxygen species,” Biochemical Journal, vol. 417, no. 1, pp. 1–13, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Brownlee, “The pathobiology of diabetic complications: a unifying mechanism,” Diabetes, vol. 54, no. 6, pp. 1615–1625, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. K. N. Frayn, D. Langin, and F. Karpe, “Fatty acid-induced mitochondrial uncoupling in adipocytes is not a promising target for treatment of insulin resistance unless adipocyte oxidative capacity is increased,” Diabetologia, vol. 51, no. 3, pp. 394–397, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Katz and R. Rognstad, “The metabolism of tritiated glucose by rat adipose tissue,” Journal of Biological Chemistry, vol. 241, no. 15, pp. 3600–3610, 1966. View at Google Scholar · View at Scopus
  19. C. Y. Han, T. Umemoto, M. Omer et al., “NADPH oxidase-derived reactive oxygen species increases expression of monocyte chemotactic factor genes in cultured adipocytes,” The Journal of Biological Chemistry, vol. 287, no. 13, pp. 10379–10393, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Bedard and K.-H. Krause, “The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology,” Physiological Reviews, vol. 87, no. 1, pp. 245–313, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Mahadev, H. Motoshima, X. Wu et al., “The NAD(P)H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transduction,” Molecular and Cellular Biology, vol. 24, no. 5, pp. 1844–1854, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Inoguchi, P. Li, F. Umeda et al., “High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells,” Diabetes, vol. 49, no. 11, pp. 1939–1945, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Dikalov, “Cross talk between mitochondria and NADPH oxidases,” Free Radical Biology and Medicine, vol. 51, no. 7, pp. 1289–1301, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. A. E. Dikalova, A. T. Bikineyeva, K. Budzyn et al., “Therapeutic targeting of mitochondrial superoxide in hypertension,” Circulation Research, vol. 107, no. 1, pp. 106–116, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Vásquez-Vivar, B. Kalyanaraman, P. Martásek et al., “Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 16, pp. 9220–9225, 1998. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Kuzkaya, N. Weissmann, D. G. Harrison, and S. Dikalov, “Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase,” The Journal of Biological Chemistry, vol. 278, no. 25, pp. 22546–22554, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. U. Förstermann and T. Münzel, “Endothelial nitric oxide synthase in vascular disease: from marvel to menace,” Circulation, vol. 113, no. 13, pp. 1708–1714, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Heitzer, C. Brockhoff, B. Mayer et al., “Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers: evidence for a dysfunctional nitric oxide synthase,” Circulation Research, vol. 86, no. 2, pp. E36–E41, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Shinozaki, A. Kashiwagi, Y. Nishio et al., “Abnormal biopterin metabolism is a major cause of impaired endothelium-dependent relaxation through nitric oxide/O2- imbalance in insulin- resistant rat aorta,” Diabetes, vol. 48, no. 12, pp. 2437–2445, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Perreault and A. Marette, “Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle,” Nature Medicine, vol. 7, no. 10, pp. 1138–1143, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Elizalde, M. Rydén, V. Van Harmelen et al., “Expression of nitric oxide synthases in subcutaneous adipose tissue of nonobese and obese humans,” Journal of Lipid Research, vol. 41, no. 8, pp. 1244–1251, 2000. View at Google Scholar · View at Scopus
  32. S. Engeli, J. Janke, K. Gorzelniak et al., “Regulation of the nitric oxide system in human adipose tissue,” Journal of Lipid Research, vol. 45, no. 9, pp. 1640–1648, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. J. M. Curtis, P. A. Grimsrud, W. S. Wright et al., “Downregulation of adipose glutathione S-tansferase A4 leads to increased protein carbonylation, oxidative stress, and mitochondrial dysfunction,” Diabetes, vol. 59, no. 5, pp. 1132–1142, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. I. Talior, T. Tennenbaum, T. Kuroki, and H. Eldar-Finkelman, “PKC-δ-dependent activation of oxidative stress in adipocytes of obese and insulin-resistant mice: Role for NADPH oxidase,” American Journal of Physiology: Endocrinology and Metabolism, vol. 288, no. 2, pp. E405–E411, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Lin, A. H. Berg, P. Iyengar et al., “The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species,” Journal of Biological Chemistry, vol. 280, no. 6, pp. 4617–4626, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Lee, Y. J. Lee, H. Choi, E. H. Ko, and J. Kim, “Reactive oxygen species facilitate adipocyte differentiation by accelerating mitotic clonal expansion,” The Journal of Biological Chemistry, vol. 284, no. 16, pp. 10601–10609, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. C.-L. Gao, C. Zhu, Y.-P. Zhao et al., “Mitochondrial dysfunction is induced by high levels of glucose and free fatty acids in 3T3-L1 adipocytes,” Molecular and Cellular Endocrinology, vol. 320, no. 1-2, pp. 25–33, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Y. Han, A. Y. Kargi, M. Omer et al., “Differential effect of saturated and unsaturated free fatty acids on the generation of monocyte adhesion and chemotactic factors by adipocytes: dissociation of adipocyte hypertrophy from inflammation,” Diabetes, vol. 59, no. 2, pp. 386–396, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. A. De Pauw, S. Tejerina, M. Raes, J. Keijer, and T. Arnould, “Mitochondrial (dys)function in adipocyte (de)differentiation and systemic metabolic alterations,” American Journal of Pathology, vol. 175, no. 3, pp. 927–939, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. V. Visentin, D. Prévot, V. D. De Saint Front et al., “Alteration of amine oxidase activity in the adipose tissue of obese subjects,” Obesity Research, vol. 12, no. 3, pp. 547–555, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Galinier, A. Carrière, Y. Fernandez et al., “Adipose tissue proadipogenic redox changes in obesity,” The Journal of Biological Chemistry, vol. 281, no. 18, pp. 12682–12687, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Galinier, A. Carriere, Y. Fernandez et al., “Site specific changes of redox metabolism in adipose tissue of obese Zucker rats,” FEBS Letters, vol. 580, no. 27, pp. 6391–6398, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. J.-F. Landrier, J. Marcotorchino, and F. Tourniaire, “Lipophilic micronutrients and adipose tissue biology,” Nutrients, vol. 4, no. 11, pp. 1622–1649, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. T. Kuno, M. Hozumi, T. Morinobu, T. Murata, Z. Mingci, and H. Tamai, “Antioxidant vitamin levels in plasma and low density lipoprotein of obese girls,” Free Radical Research, vol. 28, no. 1, pp. 81–86, 1998. View at Publisher · View at Google Scholar · View at Scopus
  45. M. L. Neuhouser, C. L. Rock, A. L. Eldridge et al., “Serum concentrations of retinol, α-tocopherol and the carotenoids are influenced by diet, race and obesity in a sample of healthy adolescents,” Journal of Nutrition, vol. 131, no. 8, pp. 2184–2191, 2001. View at Google Scholar · View at Scopus
  46. M. Blum, G. Dolnikowski, E. Seyoum et al., “Vitamin D 3 in fat tissue,” Endocrine, vol. 33, no. 1, pp. 90–94, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. R. S. Parker, “Carotenoids in human blood and tissues,” Journal of Nutrition, vol. 119, no. 1, pp. 101–104, 1989. View at Google Scholar · View at Scopus
  48. M. G. Traber and H. J. Kayden, “Tocopherol distribution and intracellular localization in human adipose tissue,” American Journal of Clinical Nutrition, vol. 46, no. 3, pp. 488–495, 1987. View at Google Scholar · View at Scopus
  49. B. D'Autréaux and M. B. Toledano, “ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis,” Nature Reviews Molecular Cell Biology, vol. 8, no. 10, pp. 813–824, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Ristow and S. Schmeisser, “Extending life span by increasing oxidative stress,” Free Radical Biology and Medicine, vol. 51, no. 2, pp. 327–336, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. L. Mao and J. Franke, “Hormesis in aging and neurodegeneration-a prodigy awaiting dissection,” International Journal of Molecular Sciences, vol. 14, no. 7, pp. 13109–13128, 2013. View at Google Scholar
  52. S. Desaint, S. Luriau, J. Aude, G. Rousselet, and M. B. Toledano, “Mammalian antioxidant defenses are not inducible by H2O2,” The Journal of Biological Chemistry, vol. 279, no. 30, pp. 31157–31163, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. E. Abuin, E. Lissi, and M. Ahumada, “Diffusion of hydrogen peroxide across DPPC large unilamellar liposomes,” Chemistry and Physics of Lipids, vol. 165, no. 6, pp. 656–661, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. R. M. Cordeiro, “Reactive oxygen species at phospholipid bilayers: distribution, mobility and permeation,” Biochimica et Biophysica Acta, vol. 1838, no. 1, part B, pp. 438–444, 2014. View at Google Scholar
  55. J. M. May and C. De Haen, “Insulin-stimulated intracellular hydrogen peroxide production in rat epididymal fat cells,” Journal of Biological Chemistry, vol. 254, no. 7, pp. 2214–2220, 1979. View at Google Scholar · View at Scopus
  56. H. I. Krieger-Brauer, P. K. Medda, and H. Kather, “Insulin-induced activation of NADPH-dependent H2O2 generation in human adipocyte plasma membranes is mediated by Gα(i2),” Journal of Biological Chemistry, vol. 272, no. 15, pp. 10135–10143, 1997. View at Publisher · View at Google Scholar · View at Scopus
  57. M. P. Czech, J. C. Lawrence Jr., and W. S. Lynn, “Evidence for the involvement of sulfhydryl oxidation in the regulation of fat cell hexose transport by insulin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 71, no. 10, pp. 4173–4177, 1974. View at Publisher · View at Google Scholar · View at Scopus
  58. G. R. Hayes and D. H. Lockwood, “Role of insulin receptor phosphorylation in the insulinomimetic effects of hydrogen peroxide,” Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 22, pp. 8115–8119, 1987. View at Publisher · View at Google Scholar · View at Scopus
  59. T. Kono, F. W. Robinson, T. L. Blevins, and O. Ezaki, “Evidence that translocation of the glucose transport activity is the major mechanism of insulin action on glucose transport in fat cells,” Journal of Biological Chemistry, vol. 257, no. 18, pp. 10942–10947, 1982. View at Google Scholar · View at Scopus
  60. S. A. Little and C. de Haen, “Effects of hydrogen peroxide on basal and hormone-stimulated lipolysis in perifused rat fat cells in relation to the mechanism of action of insulin,” Journal of Biological Chemistry, vol. 255, no. 22, pp. 10888–10895, 1980. View at Google Scholar · View at Scopus
  61. K. Mahadev, X. Wu, A. Zilbering, L. Zhu, J. T. R. Lawrence, and B. J. Goldstein, “Hydrogen peroxide generated during cellular insulin stimulation is integral to activation of the distal insulin signaling cascade in 3T3-L1 adipocytes,” The Journal of Biological Chemistry, vol. 276, no. 52, pp. 48662–48669, 2001. View at Publisher · View at Google Scholar · View at Scopus
  62. K. Loh, H. Deng, A. Fukushima et al., “Reactive oxygen species enhance insulin sensitivity,” Cell Metabolism, vol. 10, no. 4, pp. 260–272, 2009. View at Publisher · View at Google Scholar
  63. A. Rudich, N. Kozlovsky, R. Potashnik, and N. Bashan, “Oxidant stress reduces insulin responsiveness in 3T3-L1 adipocytes,” American Journal of Physiology: Endocrinology and Metabolism, vol. 272, no. 5, pp. E935–E940, 1997. View at Google Scholar · View at Scopus
  64. C. H. Wang, H. Huang, and Y. Wei, “Mitochondrial dysfunction leads to impairment of insulin sensitivity and adiponectin secretion in adipocytes,” FEBS Journal, vol. 280, no. 4, pp. 1039–1050, 2013. View at Publisher · View at Google Scholar · View at Scopus
  65. E. J. Anderson, M. E. Lustig, K. E. Boyle et al., “Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans,” Journal of Clinical Investigation, vol. 119, no. 3, pp. 573–581, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. G. Murdolo, M. Piroddi, F. Luchetti et al., “Oxidative stress and lipid peroxidation by-products at the crossroad between adipose organ dysregulation and obesity-linked insulin resistance,” Biochimie, vol. 95, no. 3, pp. 585–594, 2013. View at Publisher · View at Google Scholar · View at Scopus
  67. A. P. Russell, G. Gastaldi, E. Bobbioni-Harsch et al., “Lipid peroxidation in skeletal muscle of obese as compared to endurance-trained humans: a case of good vs. bad lipids?” FEBS Letters, vol. 551, no. 1–3, pp. 104–106, 2003. View at Publisher · View at Google Scholar · View at Scopus
  68. K. H. Ingram, H. Hill, D. R. Moellering et al., “Skeletal muscle lipid peroxidation and insulin resistance in humans,” The Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 7, pp. E1182–E1186, 2012. View at Google Scholar
  69. N. J. Pillon, M. L. Croze, R. E. Vella, L. Soulère, M. Lagarde, and C. O. Soulage, “The lipid peroxidation by-product 4-hydroxy-2-nonenal (4-HNE) induces insulin resistance in skeletal muscle through both carbonyl and oxidative stress,” Endocrinology, vol. 153, no. 5, pp. 2099–2111, 2012. View at Publisher · View at Google Scholar · View at Scopus
  70. I. Miwa, N. Ichimura, M. Sugiura, Y. Hamada, and S. Taniguchi, “Inhibition of glucose-induced insulin secretion by 4-hydroxy-2-nonenal and other lipid peroxidation products,” Endocrinology, vol. 141, no. 8, pp. 2767–2772, 2000. View at Publisher · View at Google Scholar · View at Scopus
  71. D. Demozay, J. Mas, S. Rocchi, and E. Van Obberghen, “FALDH reverses the deleterious action of oxidative stress induced by lipid peroxidation product 4-hydroxynonenal on insulin signaling in 3T3-L1 adipocytes,” Diabetes, vol. 57, no. 5, pp. 1216–1226, 2008. View at Publisher · View at Google Scholar · View at Scopus
  72. A. F. Soares, M. Guichardant, D. Cozzone et al., “Effects of oxidative stress on adiponectin secretion and lactate production in 3T3-L1 adipocytes,” Free Radical Biology and Medicine, vol. 38, no. 7, pp. 882–889, 2005. View at Publisher · View at Google Scholar · View at Scopus
  73. P. A. Grimsrud, M. J. Picklo Sr., T. J. Griffin, and D. A. Bernlohr, “Carbonylation of adipose proteins in obesity and insulin resistance: Identification of adipocyte fatty acid-binding protein as a cellular target of 4-hydroxynonenal,” Molecular and Cellular Proteomics, vol. 6, no. 4, pp. 624–637, 2007. View at Publisher · View at Google Scholar · View at Scopus
  74. X. Zhang, Z. Wang, J. Li et al., “Increased 4-hydroxynonenal formation contributes to obesity-related lipolytic activation in adipocytes,” PLoS ONE, vol. 8, no. 8, Article ID e70663, 2013. View at Publisher · View at Google Scholar · View at Scopus
  75. B. Zarrouki, A. F. Soares, M. Guichardant, M. Lagarde, and A. Géloën, “The lipid peroxidation end-product 4-HNE induces COX-2 expression through p38MAPK activation in 3T3-L1 adipose cell,” FEBS Letters, vol. 581, no. 13, pp. 2394–2400, 2007. View at Publisher · View at Google Scholar · View at Scopus
  76. R. Ye and P. E. Scherer, “Adiponectin, driver or passenger on the road to insulin sensitivity?” Molecular Metabolism, vol. 2, no. 3, pp. 133–141, 2013. View at Publisher · View at Google Scholar · View at Scopus
  77. K. Fujita, H. Nishizawa, T. Funahashi, I. Shimomura, and M. Shimabukuro, “Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome,” Circulation Journal, vol. 70, no. 11, pp. 1437–1442, 2006. View at Publisher · View at Google Scholar · View at Scopus
  78. L. Tao, E. Gao, X. Jiao et al., “Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress,” Circulation, vol. 115, no. 11, pp. 1408–1416, 2007. View at Publisher · View at Google Scholar · View at Scopus
  79. R. Li, W.-Q. Wang, H. Zhang et al., “Adiponectin improves endothelial function in hyperlipidemic rats by reducing oxidative/nitrative stress and differential regulation of eNOS/iNOS activity,” American Journal of Physiology: Endocrinology and Metabolism, vol. 293, no. 6, pp. E1703–E1708, 2007. View at Publisher · View at Google Scholar · View at Scopus
  80. K. Schröder, K. Wandzioch, I. Helmcke, and R. P. Brandes, “Nox4 acts as a switch between differentiation and proliferation in preadipocytes,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 2, pp. 239–245, 2009. View at Google Scholar
  81. M. Higuchi, G. J. Dusting, H. Peshavariya et al., “Differentiation of human adipose-derived stem cells into fat involves reactive oxygen species and forkhead box o1 mediated upregulation of antioxidant enzymes,” Stem Cells and Development, vol. 22, no. 6, pp. 878–888, 2013. View at Publisher · View at Google Scholar · View at Scopus
  82. Y. Kanda, T. Hinata, S. W. Kang, and Y. Watanabe, “Reactive oxygen species mediate adipocyte differentiation in mesenchymal stem cells,” Life Sciences, vol. 89, no. 7-8, pp. 250–258, 2011. View at Publisher · View at Google Scholar · View at Scopus
  83. K. V. Tormos, E. Anso, R. B. Hamanaka et al., “Mitochondrial complex III ROS regulate adipocyte differentiation,” Cell Metabolism, vol. 14, no. 4, pp. 537–544, 2011. View at Publisher · View at Google Scholar · View at Scopus
  84. A. Carrière, M. Carmona, Y. Fernandez et al., “Mitochondrial reactive oxygen species control the transcription factor CHOP-10/GADD153 and adipocyte differentiation: a mechanism for hypoxia-dependent effect,” Journal of Biological Chemistry, vol. 279, no. 39, pp. 40462–40469, 2004. View at Publisher · View at Google Scholar · View at Scopus
  85. A. Vidal-Puig, “Adipose tissue expandability, lipotoxicity and the metabolic syndrome,” Endocrinologia y Nutricion, vol. 60, no. 1, pp. 39–43, 2013. View at Publisher · View at Google Scholar · View at Scopus
  86. J. S. Stern, B. R. Batchelor, N. Hollander, C. K. Cohn, and J. Hirsch, “Adipose-cell size and immunoreactive insulin levels in obese and normal-weight adults.,” The Lancet, vol. 2, no. 7784, pp. 948–951, 1972. View at Google Scholar · View at Scopus
  87. M. Lundgren, M. Svensson, S. Lindmark, F. Renström, T. Ruge, and J. W. Eriksson, “Fat cell enlargement is an independent marker of insulin resistance and “hyperleptinaemia”,” Diabetologia, vol. 50, no. 3, pp. 625–633, 2007. View at Publisher · View at Google Scholar · View at Scopus
  88. T. Volk, M. Hensel, H. Schuster, and W. J. Kox, “Secretion of MCP-1 and IL-6 by cytokine stimulated production of reactive oxygen species in endothelial cells,” Molecular and Cellular Biochemistry, vol. 206, no. 1-2, pp. 105–112, 2000. View at Publisher · View at Google Scholar · View at Scopus
  89. N. S. Chandel, P. T. Schumacker, and R. H. Arch, “Reactive oxygen species are downstream products of TRAF-mediated signal transduction,” Journal of Biological Chemistry, vol. 276, no. 46, pp. 42728–42736, 2001. View at Publisher · View at Google Scholar · View at Scopus
  90. B. I. Frohnert, E. K. Long, W. S. Hahn, and D. A. Bernlohr, “Glutathionylated lipid aldehydes are products of adipocyte oxidative stress and activators of macrophage inflammation,” Diabetes, vol. 63, no. 1, pp. 89–100, 2013. View at Publisher · View at Google Scholar
  91. E. K. Long, D. M. Olson, and D. A. Bernlohr, “High-fat diet induces changes in adipose tissue trans-4-oxo-2-nonenal and trans-4-hydroxy-2-nonenal levels in a depot-specific manner,” Free Radical Biology and Medicine, vol. 63, pp. 390–398, 2013. View at Publisher · View at Google Scholar · View at Scopus
  92. Y. Zhang and X. Chen, “Reducing selenoprotein P expression suppresses adipocyte differentiation as a result of increased preadipocyte inflammation,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 300, no. 1, pp. E77–E85, 2011. View at Publisher · View at Google Scholar · View at Scopus
  93. H. Jay Forman and M. Torres, “Redox signaling in macrophages,” Molecular Aspects of Medicine, vol. 22, no. 4-5, pp. 189–216, 2001. View at Publisher · View at Google Scholar · View at Scopus
  94. C. N. Lumeng, J. L. Bodzin, and A. R. Saltiel, “Obesity induces a phenotypic switch in adipose tissue macrophage polarization,” Journal of Clinical Investigation, vol. 117, no. 1, pp. 175–184, 2007. View at Publisher · View at Google Scholar · View at Scopus
  95. D. C. Dale, L. Boxer, and W. Conrad Liles, “The phagocytes: neutrophils and monocytes,” Blood, vol. 112, no. 4, pp. 935–945, 2008. View at Publisher · View at Google Scholar · View at Scopus
  96. M. Löhn, G. Dubrovska, B. Lauterbach, F. C. Luft, M. Gollasch, and A. M. Sharma, “Periadventitial fat releases a vascular relaxing factor,” FASEB Journal, vol. 16, no. 9, pp. 1057–1063, 2002. View at Publisher · View at Google Scholar · View at Scopus
  97. G. A. Payne, H. G. Bohlen, Ü. D. Dincer, L. Borbouse, and J. D. Tune, “Periadventitial adipose tissue impairs coronary endothelial function via PKC-β-dependent phosphorylation of nitric oxide synthase,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 297, no. 1, pp. H460–H465, 2009. View at Publisher · View at Google Scholar · View at Scopus
  98. J. Ketonen, J. Shi, E. Martonen, and E. Mervaala, “Periadventitial adipose tissue promotes endothelial dysfunction via oxidative stress in diet-induced obese C57BL/6 mice,” Circulation Journal, vol. 74, no. 7, pp. 1479–1487, 2010. View at Publisher · View at Google Scholar · View at Scopus
  99. N. Hosogai, A. Fukuhara, K. Oshima et al., “Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation,” Diabetes, vol. 56, no. 4, pp. 901–911, 2007. View at Google Scholar
  100. J. L. Evans, I. D. Goldfine, B. A. Maddux, and G. M. Grodsky, “Are oxidative stress—activated signaling pathways mediators of insulin resistance and β-cell dysfunction?” Diabetes, vol. 52, no. 1, pp. 1–8, 2003. View at Publisher · View at Google Scholar · View at Scopus
  101. T. L. Archuleta, A. M. Lemieux, V. Saengsirisuwan et al., “Oxidant stress-induced loss of IRS-1 and IRS-2 proteins in rat skeletal muscle: role of p38 MAPK,” Free Radical Biology and Medicine, vol. 47, no. 10, pp. 1486–1493, 2009. View at Publisher · View at Google Scholar · View at Scopus
  102. H. Kaneto, Y. Nakatani, D. Kawamori, T. Miyatsuka, and T. Matsuoka, “Involvement of oxidative stress and the JNK pathway in glucose toxicity,” The Review of Diabetic Studies, vol. 1, no. 4, pp. 165–174, 2004. View at Google Scholar
  103. M. C. Arkan, A. L. Hevener, F. R. Greten et al., “IKK-β links inflammation to obesity-induced insulin resistance,” Nature Medicine, vol. 11, no. 2, pp. 191–198, 2005. View at Publisher · View at Google Scholar · View at Scopus
  104. J. Hirosumi, G. Tuncman, L. Chang et al., “A central, role for JNK in obesity and insulin resistance,” Nature, vol. 420, no. 6913, pp. 333–336, 2002. View at Publisher · View at Google Scholar · View at Scopus
  105. J. F. Keaney Jr., M. G. Larson, R. S. Vasan et al., “Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham study,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 3, pp. 434–439, 2003. View at Google Scholar
  106. J. Szendroedi, E. Phielix, and M. Roden, “The role of mitochondria in insulin resistance and type 2 diabetes mellitus,” Nature Reviews Endocrinology, vol. 8, no. 2, pp. 92–103, 2012. View at Publisher · View at Google Scholar · View at Scopus
  107. C. Wang and Y. Wei, “Mitochondrial dysfunction in insulin insensitivity: implication of mitochondrial role in type 2 diabetes,” Annals of the New York Academy of Sciences, vol. 1201, pp. 157–165, 2010. View at Publisher · View at Google Scholar · View at Scopus
  108. The Diabetes Control and Complications Trial Research Group, “The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus,” The New England Journal of Medicine, vol. 329, no. 14, pp. 977–986, 1993. View at Google Scholar
  109. X. Du, T. Matsumura, D. Edelstein et al., “Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells,” The Journal of Clinical Investigation, vol. 112, no. 7, pp. 1049–1057, 2003. View at Publisher · View at Google Scholar · View at Scopus
  110. K. H. Gabbay, L. O. Merola, and R. A. Field, “Sorbitol pathway: presence in nerve and cord with substrate accumulation in diabetes,” Science, vol. 151, no. 3707, pp. 209–210, 1966. View at Publisher · View at Google Scholar · View at Scopus
  111. X. L. Du, D. Edelstein, S. Dimmeler, Q. Ju, C. Sui, and M. Brownlee, “Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site,” Journal of Clinical Investigation, vol. 108, no. 9, pp. 1341–1348, 2001. View at Publisher · View at Google Scholar · View at Scopus
  112. A. Bierhaus, M. A. Hofmann, R. Ziegler, and P. P. Nawroth, “AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept,” Cardiovascular Research, vol. 37, no. 3, pp. 586–600, 1998. View at Publisher · View at Google Scholar · View at Scopus
  113. T. S. Lee, K. A. Saltsman, H. Ohashi, and G. L. King, “Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 13, pp. 5141–5145, 1989. View at Google Scholar
  114. P. Geraldes and G. L. King, “Activation of protein kinase C isoforms and its impact on diabetic complications,” Circulation Research, vol. 106, no. 8, pp. 1319–1331, 2010. View at Publisher · View at Google Scholar · View at Scopus
  115. H. Ishii, M. R. Jirousek, D. Koya et al., “Amelioration of vascular dysfunctions in diabetic rats by an oral PKC β inhibitor,” Science, vol. 272, no. 5262, pp. 728–731, 1996. View at Publisher · View at Google Scholar · View at Scopus
  116. T. Nishikawa, D. Edelstein, X. L. Du et al., “Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage,” Nature, vol. 404, no. 6779, pp. 787–790, 2000. View at Publisher · View at Google Scholar · View at Scopus
  117. B. Lu, D. Ennis, R. Lai et al., “Enhanced sensitivity of insulin-resistant adipocytes to vanadate is associated with oxidative stress and decreased reduction of vanadate (+5) to vanadyl (+4),” Journal of Biological Chemistry, vol. 276, no. 38, pp. 35589–35598, 2001. View at Publisher · View at Google Scholar · View at Scopus
  118. S. Tang, H. Le-Tien, B. J. Goldstein, P. Shin, R. Lai, and I. G. Fantus, “Decreased in situ insulin receptor dephosphorylation in hyperglycemia-induced insulin resistance in rat adipocytes,” Diabetes, vol. 50, no. 1, pp. 83–90, 2001. View at Publisher · View at Google Scholar · View at Scopus
  119. T. B. Koenen, R. Stienstra, L. J. van Tits et al., “Hyperglycemia activates caspase-1 and TXNIP-mediated IL-1β transcription in human adipose tissue,” Diabetes, vol. 60, no. 2, pp. 517–524, 2011. View at Publisher · View at Google Scholar · View at Scopus
  120. P. Björntorp, H. Bergman, and E. Varnauskas, “Plasma free fatty acid turnover rate in obesity,” Acta Medica Scandinavica, vol. 185, no. 4, pp. 351–356, 1969. View at Google Scholar · View at Scopus
  121. M. D. Jensen, M. W. Haymond, R. A. Rizza, P. E. Cryer, and J. M. Miles, “Influence of body fat distribution on free fatty acid metabolism in obesity,” Journal of Clinical Investigation, vol. 83, no. 4, pp. 1168–1173, 1989. View at Publisher · View at Google Scholar · View at Scopus
  122. G. Paolisso, G. Di Maro, G. Pizza et al., “Plasma GSH/GSSG affects glucose homeostasis in healthy subjects and non- insulin-dependent diabetics,” American Journal of Physiology: Endocrinology and Metabolism, vol. 263, no. 3, part 2, pp. E435–E440, 1992. View at Google Scholar · View at Scopus
  123. L. Wojtczak and P. Schonfeld, “Effect of fatty acids on energy coupling processes in mitochondria,” Biochimica et Biophysica Acta—Bioenergetics, vol. 1183, no. 1, pp. 41–57, 1993. View at Publisher · View at Google Scholar · View at Scopus
  124. L. F. van Gaal, J. Vertommen, and I. H. de Leeuw, “The in vitro oxidizability of lipoprotein particles in obese and non- obese subjects,” Atherosclerosis, vol. 137, supplement, pp. S39–S44, 1998. View at Publisher · View at Google Scholar · View at Scopus
  125. A. Bouloumié, T. Marumo, M. Lafontan, and R. Busse, “Leptin induces oxidative stress in human endothelial cells,” FASEB Journal, vol. 13, no. 10, pp. 1231–1238, 1999. View at Google Scholar · View at Scopus
  126. S. Yamagishi, D. Edelstein, X. Du, Y. Kaneda, M. Guzmán, and M. Brownlee, “Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A,” The Journal of Biological Chemistry, vol. 276, no. 27, pp. 25096–25100, 2001. View at Publisher · View at Google Scholar · View at Scopus
  127. L. Li, J. Mamputu, N. Wiernsperger, and G. Renier, “Signaling pathways involved in human vascular smooth muscle cell proliferation and matrix metalloproteinase-2 expression induced by leptin: inhibitory effect of metformin,” Diabetes, vol. 54, no. 7, pp. 2227–2234, 2005. View at Publisher · View at Google Scholar · View at Scopus
  128. F. Maingrette and G. Renier, “Leptin increases lipoprotein lipase secretion by macrophages: involvement of oxidative stress and protein kinase C,” Diabetes, vol. 52, no. 8, pp. 2121–2128, 2003. View at Publisher · View at Google Scholar · View at Scopus
  129. J. Bełtowski, G. Wójcicka, and A. Jamroz, “Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress: The possible novel mechanism for proatherogenic effect of chronic hyperleptinemia,” Atherosclerosis, vol. 170, no. 1, pp. 21–29, 2003. View at Publisher · View at Google Scholar · View at Scopus
  130. L. A. Cassis, S. B. Police, F. Yiannikouris, and S. E. Thatcher, “Local adipose tissue renin-angiotensin system,” Current Hypertension Reports, vol. 10, no. 2, pp. 93–98, 2008. View at Publisher · View at Google Scholar · View at Scopus
  131. S. Engeli, P. Schling, K. Gorzelniak et al., “The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?” International Journal of Biochemistry and Cell Biology, vol. 35, no. 6, pp. 807–825, 2003. View at Publisher · View at Google Scholar · View at Scopus
  132. K. K. Griendling, C. A. Minieri, J. D. Ollerenshaw, and R. W. Alexander, “Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells,” Circulation Research, vol. 74, no. 6, pp. 1141–1148, 1994. View at Publisher · View at Google Scholar · View at Scopus
  133. R. P. Brandes and J. Kreuzer, “Vascular NADPH oxidases: molecular mechanisms of activation,” Cardiovascular Research, vol. 65, no. 1, pp. 16–27, 2005. View at Publisher · View at Google Scholar · View at Scopus
  134. A. Kurata, H. Nishizawa, S. Kihara et al., “Blockade of angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation,” Kidney International, vol. 70, no. 10, pp. 1717–1724, 2006. View at Publisher · View at Google Scholar · View at Scopus
  135. P. Dandona, P. Mohanty, H. Ghanim et al., “The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation,” The Journal of Clinical Endocrinology & Metabolism, vol. 86, no. 1, pp. 355–362, 2001. View at Publisher · View at Google Scholar · View at Scopus
  136. A. B. Crujeiras, D. Parra, F. I. Milagro et al., “Differential expression of oxidative stress and inflammation related genes in peripheral blood mononuclear cells in response to a low-calorie diet: a nutrigenomics study,” OMICS, vol. 12, no. 4, pp. 251–261, 2008. View at Publisher · View at Google Scholar · View at Scopus
  137. C. Cantó and J. Auwerx, “Targeting sirtuin 1 to improve metabolism: All you need is NAD+?” Pharmacological Reviews, vol. 64, no. 1, pp. 166–187, 2012. View at Publisher · View at Google Scholar · View at Scopus
  138. V. Perrot and M. M. Rechler, “Characterization of insulin inhibition of transactivation by a C-terminal fragment of the forkhead transcription factor Foxo1 in rat hepatoma cells,” The Journal of Biological Chemistry, vol. 278, no. 28, pp. 26111–26119, 2003. View at Publisher · View at Google Scholar · View at Scopus
  139. A. Brunet, L. B. Sweeney, J. F. Sturgill et al., “Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase,” Science, vol. 303, no. 5666, pp. 2011–2015, 2004. View at Publisher · View at Google Scholar · View at Scopus
  140. D. R. Calnan and A. Brunet, “The FoxO code,” Oncogene, vol. 27, no. 16, pp. 2276–2288, 2008. View at Publisher · View at Google Scholar · View at Scopus
  141. G. López-Lluch, N. Hunt, B. Jones et al., “Calorie restriction induces mitochondrial biogenesis and bioenergetic efficiency,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 6, pp. 1768–1773, 2006. View at Publisher · View at Google Scholar · View at Scopus
  142. M.-C. Gomez-Cabrera, E. Domenech, and J. Viña, “Moderate exercise is an antioxidant: upregulation of antioxidant genes by training,” Free Radical Biology and Medicine, vol. 44, no. 2, pp. 126–131, 2008. View at Publisher · View at Google Scholar · View at Scopus
  143. N. G. Boulé, S. J. Weisnagel, T. A. Lakka et al., “Effects of exercise training on glucose homeostasis: the HERITAGE family study,” Diabetes Care, vol. 28, no. 1, pp. 108–114, 2005. View at Publisher · View at Google Scholar · View at Scopus
  144. F. G. S. Toledo, E. V. Menshikova, V. B. Ritov et al., “Effects of physical activity and weight loss on skeletal muscle mitochondria and relationship with glucose control in type 2 diabetes,” Diabetes, vol. 56, no. 8, pp. 2142–2147, 2007. View at Publisher · View at Google Scholar · View at Scopus
  145. B. Balkau, L. Mhamdi, J. Oppert et al., “Physical activity and insulin sensitivity the RISC study,” Diabetes, vol. 57, no. 10, pp. 2613–2618, 2008. View at Publisher · View at Google Scholar · View at Scopus
  146. P. M. Kris-Etherton, W. S. Harris, and L. J. Appel, “Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 2, pp. 151–152, 2003. View at Publisher · View at Google Scholar · View at Scopus
  147. P. C. Calder, “n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases,” The American Journal of Clinical Nutrition, vol. 83, no. 6, 2006. View at Google Scholar · View at Scopus
  148. A. González-Périz, R. Horrillo, N. Ferré et al., “Obesity-induced insulin resistance and hepatic steatosis are alleviated by ω-3 fatty acids: A role for resolvins and protectins,” The FASEB Journal, vol. 23, no. 6, pp. 1946–1957, 2009. View at Publisher · View at Google Scholar · View at Scopus
  149. C. Fan, H. Zirpoli, and K. Qi, “N-3 fatty acids modulate adipose tissue inflammation and oxidative stress,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 16, no. 2, pp. 124–132, 2013. View at Publisher · View at Google Scholar · View at Scopus
  150. S. Schmidt, F. Stahl, K. Mutz, T. Scheper, A. Hahn, and J. P. Schuchardt, “Transcriptome-based identification of antioxidative gene expression after fish oil supplementation in normo- and dyslipidemic men,” Nutrition and Metabolism, vol. 9, no. 1, article 45, 2012. View at Publisher · View at Google Scholar · View at Scopus
  151. C. Kusunoki, L. Yang, T. Yoshizaki et al., “Omega-3 polyunsaturated fatty acid has an anti-oxidant effect via the Nrf-2/HO-1 pathway in 3T3-L1 adipocytes,” Biochemical and Biophysical Research Communications, vol. 430, no. 1, pp. 225–230, 2013. View at Publisher · View at Google Scholar · View at Scopus
  152. M. Spencer, B. S. Finlin, R. Unal et al., “Omega-3 fatty acids reduce adipose tissue macrophages in human subjects with insulin resistance,” Diabetes, vol. 62, no. 5, pp. 1709–1717, 2013. View at Publisher · View at Google Scholar · View at Scopus
  153. A. Moor De Burgos, M. Wartanowicz, and S. Ziemlariski, “Blood vitamin and lipid levels in overweight and obese women,” European Journal of Clinical Nutrition, vol. 46, no. 11, pp. 803–808, 1992. View at Google Scholar · View at Scopus
  154. R. S. Strauss, “Comparison of serum concentrations of α-tocopherol and β-carotene in a cross-sectional sample of obese and nonobese children (NHANES III),” Journal of Pediatrics, vol. 134, no. 2, pp. 160–165, 1999. View at Publisher · View at Google Scholar · View at Scopus
  155. A. Esfahani, J. M. W. Wong, J. Truan et al., “Health effects of mixed fruit and vegetable concentrates: a systematic review of the clinical interventions,” Journal of the American College of Nutrition, vol. 30, no. 5, pp. 285–294, 2011. View at Publisher · View at Google Scholar · View at Scopus
  156. I. Savini, M. V. Catani, D. Evangelista, V. Gasperi, and L. Avigliano, “Obesity-associated oxidative stress: strategies finalized to improve redox state,” International Journal of Molecular Sciences, vol. 14, no. 5, pp. 10497–10538, 2013. View at Publisher · View at Google Scholar · View at Scopus
  157. G. Bjelakovic, D. Nikolova, L. L. Gluud, R. G. Simonetti, and C. Gluud, “Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis,” The Journal of the American Medical Association, vol. 297, no. 8, pp. 842–857, 2007. View at Publisher · View at Google Scholar · View at Scopus
  158. G. Bjelakovic, A. Nagorni, D. Nikolova, R. G. Simonetti, M. Bjelakovic, and C. Gluud, “Meta-analysis: Antioxidant supplements for primary and secondary prevention of colorectal adenoma,” Alimentary Pharmacology and Therapeutics, vol. 24, no. 2, pp. 281–291, 2006. View at Publisher · View at Google Scholar · View at Scopus
  159. P. T. Schumacker, “Reactive oxygen species in cancer cells: live by the sword, die by the sword,” Cancer Cell, vol. 10, no. 3, pp. 175–176, 2006. View at Publisher · View at Google Scholar · View at Scopus
  160. R. Andriantsitohaina, L. Duluc, J. C. García-Rodríguez et al., “Systems biology of antioxidants,” Clinical Science, vol. 123, no. 3, pp. 173–192, 2012. View at Publisher · View at Google Scholar
  161. R. Andriantsitohaina, C. Auger, T. Chataigneau et al., “Molecular mechanisms of the cardiovascular protective effects of polyphenols,” The British Journal of Nutrition, vol. 108, no. 9, pp. 1532–1549, 2012. View at Publisher · View at Google Scholar · View at Scopus
  162. A. Agouni, A. Lagrue-Lak-Hal, H. A. Mostefai et al., “Red wine polyphenols prevent metabolic and cardiovascular alterations associated with obesity in Zucker fatty rats (Fa/Fa),” PLoS ONE, vol. 4, no. 5, Article ID e5557, 2009. View at Publisher · View at Google Scholar · View at Scopus
  163. J. A. Baur, K. J. Pearson, N. L. Price et al., “Resveratrol improves health and survival of mice on a high-calorie diet,” Nature, vol. 444, no. 7117, pp. 337–342, 2006. View at Publisher · View at Google Scholar · View at Scopus
  164. L. Rivera, R. Morón, A. Zarzuelo, and M. Galisteo, “Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats,” Biochemical Pharmacology, vol. 77, no. 6, pp. 1053–1063, 2009. View at Publisher · View at Google Scholar · View at Scopus
  165. L. Rivera, R. Morón, M. Sánchez, A. Zarzuelo, and M. Galisteo, “Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats,” Obesity, vol. 16, no. 9, pp. 2081–2087, 2008. View at Publisher · View at Google Scholar · View at Scopus
  166. S. Wang, N. Moustaid-Moussa, L. Chen et al., “Novel insights of dietary polyphenols and obesity,” The Journal of Nutritional Biochemistry, vol. 25, no. 1, pp. 1–18, 2014. View at Google Scholar
  167. S. Hatia, A. Septembre-Malaterre, F. Le Sage et al., “Evaluation of antioxidant properties of major dietary polyphenols and their protective effect on 3T3-L1 preadipocytes and red blood cells exposed to oxidative stress,” Free Radical Research, vol. 48, no. 4, pp. 387–401, 2014. View at Google Scholar
  168. A. Ejaz, D. Wu, P. Kwan, and M. Meydani, “Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice,” Journal of Nutrition, vol. 139, no. 5, pp. 919–925, 2009. View at Publisher · View at Google Scholar · View at Scopus
  169. P. Fischer-Posovszky, V. Kukulus, D. Tews et al., “Resveratrol regulates human adipocyte number and function in a Sirt1-dependent manner,” The American Journal of Clinical Nutrition, vol. 92, no. 1, pp. 5–15, 2010. View at Publisher · View at Google Scholar · View at Scopus
  170. H.-J. Park, U. J. Jung, M.-K. Lee et al., “Modulation of lipid metabolism by polyphenol-rich grape skin extract improves liver steatosis and adiposity in high fat fed mice,” Molecular Nutrition & Food Research, vol. 57, no. 2, pp. 360–364, 2013. View at Publisher · View at Google Scholar · View at Scopus
  171. C. Tian, X. Ye, R. Zhang et al., “Green Tea Polyphenols Reduced Fat Deposits in High Fat-Fed Rats via erk1/2-PPARγ-Adiponectin Pathway,” PLoS ONE, vol. 8, no. 1, Article ID e53796, 2013. View at Publisher · View at Google Scholar · View at Scopus
  172. S. Uchiyama, Y. Taniguchi, A. Saka, A. Yoshida, and H. Yajima, “Prevention of diet-induced obesity by dietary black tea polyphenols extract in vitro and in vivo,” Nutrition, vol. 27, no. 3, pp. 287–292, 2011. View at Publisher · View at Google Scholar · View at Scopus
  173. P. J. Turnbaugh, R. E. Ley, M. A. Mahowald, V. Magrini, E. R. Mardis, and J. I. Gordon, “An obesity-associated gut microbiome with increased capacity for energy harvest,” Nature, vol. 444, no. 7122, pp. 1027–1031, 2006. View at Publisher · View at Google Scholar · View at Scopus
  174. V. K. Ridaura, J. J. Faith, F. E. Rey et al., “Gut microbiota from twins discordant for obesity modulate metabolism in mice,” Science, vol. 341, no. 6150, Article ID 1241214, 2013. View at Google Scholar
  175. S. Bolca, T. van de Wiele, and S. Possemiers, “Gut metabotypes govern health effects of dietary polyphenols,” Current Opinion in Biotechnology, vol. 24, no. 2, pp. 220–225, 2013. View at Publisher · View at Google Scholar · View at Scopus
  176. M. Ahmadian, J. M. Suh, N. Hah et al., “PPARγ signaling and metabolism: the good, the bad and the future,” Nature Medicine, vol. 19, no. 5, pp. 557–566, 2013. View at Publisher · View at Google Scholar
  177. L. Wilson-Fritch, A. Burkart, G. Bell et al., “Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone,” Molecular and Cellular Biology, vol. 23, no. 3, pp. 1085–1094, 2003. View at Publisher · View at Google Scholar · View at Scopus
  178. L. Wilson-Fritch, S. Nicoloro, M. Chouinard et al., “Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone,” The Journal of Clinical Investigation, vol. 114, no. 9, pp. 1281–1289, 2004. View at Publisher · View at Google Scholar · View at Scopus
  179. H. Ohno, K. Shinoda, B. M. Spiegelman, and S. Kajimura, “PPARγ agonists induce a white-to-brown fat conversion through stabilization of PRDM16 protein,” Cell Metabolism, vol. 15, no. 3, pp. 395–404, 2012. View at Publisher · View at Google Scholar · View at Scopus
  180. L. Qiang, L. Wang, N. Kon et al., “Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of Pparγ,” Cell, vol. 150, no. 3, pp. 620–632, 2012. View at Publisher · View at Google Scholar · View at Scopus
  181. J. Boucher, B. Masri, D. Daviaud et al., “Apelin, a newly identified adipokine up-regulated by insulin and obesity,” Endocrinology, vol. 146, no. 4, pp. 1764–1771, 2005. View at Publisher · View at Google Scholar · View at Scopus
  182. C. Dray, C. Knauf, D. Daviaud et al., “Apelin stimulates glucose utilization in normal and obese insulin-resistant mice,” Cell Metabolism, vol. 8, no. 5, pp. 437–445, 2008. View at Publisher · View at Google Scholar · View at Scopus
  183. P. Yue, H. Jin, S. Xu et al., “Apelin decreases lipolysis via Gq, Gi, and AMPK-dependent mechanisms,” Endocrinology, vol. 152, no. 1, pp. 59–68, 2011. View at Publisher · View at Google Scholar · View at Scopus
  184. A. Than, Y. Cheng, L. Foh et al., “Apelin inhibits adipogenesis and lipolysis through distinct molecular pathways,” Molecular and Cellular Endocrinology, vol. 362, no. 1-2, pp. 227–241, 2012. View at Publisher · View at Google Scholar · View at Scopus
  185. C. Foussal, O. Lairez, D. Calise et al., “Activation of catalase by apelin prevents oxidative stress-linked cardiac hypertrophy,” FEBS Letters, vol. 584, no. 11, pp. 2363–2370, 2010. View at Publisher · View at Google Scholar · View at Scopus
  186. H. J. Chun, Z. A. Ali, Y. Kojima et al., “Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis,” The Journal of Clinical Investigation, vol. 118, no. 10, pp. 3343–3354, 2008. View at Publisher · View at Google Scholar · View at Scopus
  187. X. J. Zeng, S. P. Yu, L. Zhang, and L. Wei, “Neuroprotective effect of the endogenous neural peptide apelin in cultured mouse cortical neurons,” Experimental Cell Research, vol. 316, no. 11, pp. 1773–1783, 2010. View at Publisher · View at Google Scholar · View at Scopus
  188. W. Hung, T. Hsieh, T. Lin et al., “Blockade of the renin-angiotensin system ameliorates apelin production in 3T3-L1 adipocytes,” Cardiovascular Drugs and Therapy, vol. 25, no. 1, pp. 3–12, 2011. View at Publisher · View at Google Scholar · View at Scopus
  189. C. Vickers, P. Hales, V. Kaushik et al., “Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase,” Journal of Biological Chemistry, vol. 277, no. 17, pp. 14838–14843, 2002. View at Publisher · View at Google Scholar · View at Scopus
  190. S. Lorente-Cebrián, M. Bustos, A. Marti, J. A. Martinez, and M. J. Moreno-Aliaga, “Eicosapentaenoic acid up-regulates apelin secretion and gene expression in 3T3-L1 adipocytes,” Molecular Nutrition and Food Research, vol. 54, no. 1, pp. S104–S111, 2010. View at Publisher · View at Google Scholar · View at Scopus
  191. X. Iturrioz, R. Alvear-Perez, N. de Mota et al., “Identification and pharmacological properties of E339-3D6, the first nonpeptidic apelin receptor agonist,” The FASEB Journal, vol. 24, no. 5, pp. 1506–1517, 2010. View at Publisher · View at Google Scholar · View at Scopus
  192. F. Addabbo, M. Montagnani, and M. S. Goligorsky, “Mitochondria and reactive oxygen species,” Hypertension, vol. 53, no. 6, pp. 885–892, 2009. View at Publisher · View at Google Scholar · View at Scopus